Bacri J L, Dechaux M, André J L, Gagnadoux M F, Broyer M
Arch Fr Pediatr. 1981 Dec;38 Suppl 1:887-92.
Twenty patients with severe arterial hypertension were treated with Captopril (an inhibitor of angiotensin 1 converting enzyme). Decrease in blood pressure occurred early and was sometimes important. Significant changes in plasma renin activity, plasma aldosterone and converting enzyme activity were observed. There was a significant inverse correlation between the action of Captopril on blood pressure and the level of extra-cellular volumes. Eighteen patients received long-term treatment (m = 10.05 +/- 1.32 mo.). Side-effects consisted of positive antinuclear antibodies and a possible kidney failure in cases with stenosis of the renal artery.
20名重度动脉高血压患者接受了卡托普利(一种血管紧张素I转换酶抑制剂)治疗。血压下降出现得早,有时降幅很大。观察到血浆肾素活性、血浆醛固酮和转换酶活性有显著变化。卡托普利对血压的作用与细胞外液量水平之间存在显著负相关。18名患者接受了长期治疗(平均10.05±1.32个月)。副作用包括抗核抗体阳性以及肾动脉狭窄病例中可能出现的肾衰竭。